Integrity / innovation / cooperation / sharing / win-w±in

Operation mode

Corporate planning, administration, R&D, finance, procurement and management

The company focuses on building five platforms

Realize the two-way full coverage of CMC (CRO MAH CDMO) pharmaceutical R&D♣, manufacturing, intermediate and API procurement, production and sales industry chain. And rea‌lize the group's integrated operation through MAH.

Shanghai Union Biomedical

　　Industry finance capital platform with higher growth vaφlue engaged in sales, import and export of APIs and intermediates, re<search and development of advanced biopharmaceuticals, and reseaλrch and development of intelligent medical devices.

Anhui Union Biomedical

　　R&D and application and registration (MAH) platform engaged in API quality research and σformulation research and development, including formulation improvement, advanced< and featured formulations such as controlled rele±ase preparations, compound preparations, mouth soluble membrane preparations etc.

API production platform

Advanced manufacturing platform with GMP quality system and standardized EHS system for API, adv‌anced intermediates and small-scale production of CDMO with supporting facilitates like c♥lean area and etc.

Intermediate production platform

Manufacturing platform with GMP quality system and standardized EHS system for adv>anced intermediates and small-scale production of CDMO with one hydrogenation workshop a nd one DCS production workshop.

-Operation mode-

CRO

Custom synthesis

CDMO

Customized production

OEM

Commissioned production

RDC

Cooperative R&D

-Production mode-